News
All News
Dosing & Delivery Innovations
Press Releases
Product Approvals and Launches
Watch
Expert Conversations
News & Analysis
Shows & Podcasts
Journals
All Journals
The American Journal of Managed Care
Population Health, Equity & Outcomes
Evidence-Based Oncology
About Supplements and Featured Publications
Supplements and Featured Publications Issues
Submit a Manuscript
Conferences
Conference Coverage
Conference Listing
Post Conference Perspectives
More
Events
AJMC Events
Events Calendar
Institute for Value-Based Medicine
Patient-Centered Oncology Care
Population Health Roundtables
Webinars
Resources
Interactive Tools
Formulary Central
Clinical Spotlight
Microsites
Sponsored Content
CE
About AJMC
AJMC Staff
Anniversary
Seema Sonnad Award
Strategic Alliance Partners
Subscribe
My Account
News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe
Biosimilars
Cardiorenalmetabolic
Cardiomyopathy
Cardiovascular
Chronic Kidney Disease
Diabetes
Heart Failure
Type 1 Diabetes
Dermatology
Alopecia
Atopic Dermatitis
Chronic Hand Eczema
Psoriasis
Gastroenterology
Hematology
ALL/AML
CLL/SLL
GVHD
Hemophilia
Mantle Cell Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Rare Blood
Hepatology
Hepatitis
Liver
MASH
Immunology
Allergy
Autoimmune
Inflammation
Lupus
Myasthenia Gravis
Rheumatoid Arthritis
Infectious Disease
COVID-19
HIV
RSV
Vaccines
Mental Health
Major Depressive Disorder
Sleep
Neurology
Duchenne Muscular Dystrophy
Epilepsy
Multiple Sclerosis
Parkinson Disease
Obesity
Oncology
Breast Cancer
Cholangiocarcinoma
Colorectal Cancer
Immuno-Oncology
Liver Cancer
Non–Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Small Cell Lung Cancer
Soft Tissue Sarcoma
Ophthalmology
Pulmonology
COPD
Pulmonary Arterial Hypertension
Rare Disease
Spinal Muscular Atrophy
Respiratory
Asthma
Pulmonary Fibrosis
Rheumatology
Urology
Overactive Bladder
Women's Health
Endometriosis
Biosimilars
Bispecifics Network
Center on Health Equity & Access
Digital Health
Dosing & Delivery Innovations
Formulary
Gene Therapy
Guidelines
Health Care Administration
Employers
Medicare
Reimbursement
Health Care Cost
Health Care Delivery
Insurance
Policy
Population Health
Product Approvals and Launches
Technology
Value-Based Care
Choose Specialty
Topics
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement
Considering Cost Effectiveness in Cardiovascular Risk Reduction
EP. 1: Economic Burden of Cardiovascular Disease
September 16th 2020
EP. 2: Risk Assessment for Cardiovascular Disease
September 16th 2020
EP. 3: LDL Cholesterol Lowering and CV Risk
September 16th 2020
EP. 4: Cardiovascular Risk Management
September 16th 2020
EP. 5: Dyslipidemia: Strategies Used to Reduce CV Risk
September 16th 2020
EP. 6: Statin Therapy for LDL Reduction and CV Risk
September 16th 2020
EP. 7: Statin Therapy: Risk for Future CV Events
September 16th 2020
EP. 8: PCSK9 Inhibitors and CV Risk
September 16th 2020
EP. 9: Dyslipidemia: Cost-Utilization of PCSK9 Inhibitors
September 16th 2020
EP. 10: Targeting Triglycerides to Reduce CV Risk
September 16th 2020
EP. 11: The REDUCE-IT Study and CV Risk
September 16th 2020
EP. 12: Interim Analysis of EVAPORATE
September 16th 2020
EP. 13: Coronary Plaque Regression and CV Risk
September 16th 2020
EP. 14: Implications for Treating Patients With Icosapent Ethyl
September 16th 2020
EP. 15: Cost-Effectiveness and Cardiovascular Risk
September 16th 2020
EP. 16: Cardiovascular Disease Treatment Decisions and Cost
September 16th 2020
EP. 17: CV Risk Reduction and Coverage of Therapies
September 16th 2020
EP. 18: Cost-Effectiveness Data and Pricing of Icosapent Ethyl
September 16th 2020
EP. 19: CVD: Cost-Effectiveness Data and Treatment Selection
September 16th 2020
EP. 20: Clinical Pathways for Cardiovascular Disease Management
September 16th 2020
EP. 21: Better Strategies to Reduce Cardiovascular Events
September 16th 2020
Advertisement
Advertisement
Trending on AJMC
1
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
2
How Long-Acting Injectables Are Changing HIV Care
3
Less-Intensive Leukemia Regimen Outperforms Standard Chemo
4
Evolocumab Cuts Death Risk for a First Heart Attack or Stroke
5
Inside Myeloma’s Evolution From Death Sentence to Cure
